Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Prioritisation programme

Prioritisation programme

Decision

Decision

Showing 101 to 110 of 386

TitlePrioritisation programmeDecisionDecision date
Selumetinib granules for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children 1 to 6 years [TSID12092]None selectedNot selected
Prolonged-release diazoxide choline for treating Prader-Willi syndrome [ID1389]None selectedAwaiting decision
Evinacumab for treating homozygous familial hypercholesterolemia in children aged 6 months to 11 [TSID11806]None selectedNot selected
Lomitapide for treating homozygous familial hypercholesterolaemia in people 5 to 17 years [TSID 12085]None selectedNot selected
Ustekinumab for the treatment of moderately to severely active Crohn's disease in children [TS ID 11955]None selectedn/a
Mexiletine hydrochloride for treating myotonia in children and adolescents with myotonic disorders [TS ID 11978]None selectedNot selected
Henlius (pertuzumab biosimilar) for treating HER2-positive breast cancer [TS ID 12094]None selectedNot selected
Sumatriptan–naproxen for treating migraine-related moderate to severe headache [TS ID 12055]None selectedNot selected
Linaclotide acetate for treating Chronic idiopathic constipation [TSID12005]None selectedNot selected
Human normal immunoglobulin for preventing infection in chronic lymphocytic leukaemia [TSID12043]None selectedNot selected

Results per page

  1. 10
  2. 25
  3. 50
  4. All